Lynn Kramer

Clinical trial for BAN2401 in early Alzheimer’s: combining ADCOMS and Bayesian statistics 10:19
Clinical trial for BAN2401 in early Alzheimer’s: combining ADCOMS and Bayesian statistics
Lynn Kramer • 22 Jul 2018
Outstanding amyloid response to BAN2401: slowing progression in early Alzheimer’s 11:32
Outstanding amyloid response to BAN2401: slowing progression in early Alzheimer’s
Lynn Kramer et al. • 22 Jul 2018
The content of VJDementia is intended for healthcare professionals